https://iris.uniupo.it/handle/11579/106376
Photoacoustic ratiometric assessment of mitoxantrone release from theranostic ICG-conjugated...
assessmentmitoxantronereleaseicg
https://medlineplus.gov/druginfo/meds/a608019.html
Mitoxantrone Injection: MedlinePlus Drug Information
Mitoxantrone Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus
drug informationmitoxantroneinjectionmedlineplus
https://avesis.omu.edu.tr/yayin/d75bd2be-a657-495f-ab8f-4be3f3ed3400/mitoxantrone-release-from-fmoc-protected-amino-acids-coated-magnetic-carbon-nanotubes-computational-and-experimental-study-for-cancer-treatment
Mitoxantrone release from Fmoc-protected amino acids coated magnetic carbon nanotubes:...
protected amino acidscarbon nanotubesmitoxantronereleasecoated
https://ricerca.uniba.it/handle/11586/10901
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS...
risk factorsmultiple sclerosisfrequencymitoxantroneamenorrhea
https://seer.cancer.gov/oncologytoolbox/canmed/hcpcs/1089/
J9293 Mitoxantrone - CanMED: HCPCS
CanMED: HCPCS. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
mitoxantronehcpcs
https://www.breastcancer.org/drugs/mitoxantrone
Mitoxantrone: What to Expect, Side Effects, and More
Mitoxantrone (brand name: Novantrone) is an anthracycline chemotherapy medicine used to treat advanced-stage breast cancer.
what to expectside effectsand moremitoxantrone
https://adisinsight.springer.com/drugsafety/803870579?error=cookies_not_supported&code=a56ebd1a-858d-472c-8761-4e6e0e95ccfb
Cytarabine/mitoxantrone - AdisInsight
In a prospective study involving 8 patients conducted between December 2019 and January 2024, a woman [age not stated] was described who exhibited lack of
mitoxantrone